.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India’s flagship health insurance programme has significantly improved access to oncology treatments. Ayushman Bharat cancer care serves as a critical lifeline for rural and low-income populations facing high medical costs. However, while the scheme has covered millions of treatments, significant financial gaps persist. Experts emphasize that the current allocation often falls short of the comprehensive care required for long-term survival.
The FinCan study highlights that the program requires an annual budget of ₹33,000 crore to provide full standard-of-care services. Currently, the allocation stands at roughly ₹7,700 crore per year. Consequently, this disparity limits the ability of many families to access advanced therapies. Therefore, researchers recommend shifting from a ₹5 lakh annual cap to a ₹25 lakh revolving ceiling over five years. This change would allow patients to utilize more funds during high-cost treatment phases.
Early detection remains the most effective way to reduce the economic and clinical burden of oncology. Furthermore, integrating diagnostic coverage into the scheme could save approximately ₹1,500 crore annually. By aligning screening protocols with global benchmarks, India could potentially save over 30,000 additional lives each year. Moreover, the 2025-26 Union Budget has already earmarked funds for 200 new day-care cancer centers to expand rural access. These steps indicate a positive move toward universal health coverage.
Q1: How does the FinCan study suggest improving cancer funding?
The study recommends a ₹25 lakh revolving ceiling for families and a ₹10 lakh top-up for high-stage cancer patients.
Q2: Why is early diagnosis emphasized in the new study?
Early diagnosis and treatment initiation can save ₹1,500 crore annually and prevent late-stage suffering while improving survival rates.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The FinCan study advocates for restructured AB-PMJAY funding and early diagnosis to enhance cancer survival rates and reduce financial burdens in India....
4 months ago
New toxicological research evaluates heavy metal contamination in encapsulated green tea supplements, revealing that lead intake can exceed permitted daily exposure limits. The findings highlight the critical need for exposure-based risk assessment in botanical formulations.
Today
A prospective study evaluates the fetal Evans Index in late-onset fetal growth restriction, uncovering anterior cerebral remodeling rather than ventriculomegaly, with conventional growth metrics retaining primary prognostic power for neonatal intensive care unit admission.
Today
Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today
Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today
Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today
